Should Patients with Implantable Cardioverter-Defibrillators Be Allowed to Drive? Observations in 291 Patients from a Single Center over an 11-year Period

Journal of Interventional Cardiac Electrophysiology

Volumn 2, Issue 2, 1998, Pages 193-201

  Trappe, Hans Joachim ^a,b   Wenzlaff, Paul ^a   Grellman, Gert ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Accidents; Automatic implantable cardioverter defibrillator; Driving behavior; Motor vehicle driving

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CAR DRIVING; CHILD; DEFIBRILLATOR; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; FORECASTING; GERMANY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INCIDENCE; LEGAL ASPECT; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTOR; SAFETY; STATISTICS; SYNCOPE; TIME; TRAFFIC ACCIDENT;

ACCIDENTS, TRAFFIC; ADOLESCENT; ADULT; AGED; AUTOMOBILE DRIVING; CHILD; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; FORECASTING; GERMANY; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SAFETY; SYNCOPE; TACHYCARDIA, VENTRICULAR; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 0032083045     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009763818159     Document Type: Article

References (25)

1. Jimenez RA, Myerburg RJ. Sudden cardiac death: Magnitude of the problem, substrate/trigger interaction, and populations at high risk. In: Akhtar M, ed. Cardiology Clinics. Philadelphia: WB Saunders, 1993, pp. 1-9.
2. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412.
3. The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992;327:227-233.
4. Trappe HJ, Pfitzner P, Fieguth HG, Wenzlaff P, Kielblock B, Klein H. Nonpharmacological therapy of ventricular tachyarrhythmias: Observations in 554 patients. PACE 1994; 17(Part II):2172-2177.
5. Nisam S, Kaye SA, Mower MM, Hull M. AICD™ automatic cardioverter defibrillator clinical update: 14 years experience in over 34,000 patients. PACE Pacing Clin Electrophysiol 1995;18 (Part II):142-147.
6. Anderson MH, Camm AJ. Legal and ethical aspects of driving and working in patients with an implantable cardioverter defibrillator. Am Heart J 1994;127:1185-1193.
7. Trappe HJ, Klein H, Kielblock B. Role of antitachycardia pacing in patients with third generation cardioverter defibibrillators. PACE 1994;17:506-513.
8. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees. The Wadsworth Statistical Probability Series 1984.
9. Curtis AB, Conti JB, Tucker KJ, Kubilis PS, Reilly RE, Woodard DA. Motor vehicle accidents in patients with an implantable cardioverter-defibrillator. J Am Coll Cardiol 1995;26:180-184.
10. Consensus Conference, Canadian Cardiovascular Society. Assessment of the cardiac patient for fitness to drive. Can J Cardiol 1992;8:406-411.
11. Reiter MJ, Fain ES, Senelly KM. Determinants of recurrent ventricular arrhythmias in patients with implantable pacemaker/defibrillators. Circulation 1991;84 (Suppl. II):426 (Abstract).
12. Levine JH, Mellits D, Baumgardner RA, Veltri EP, Mower M, Grunwald L, Guarnieri T, Aarons D, Griffith LSC. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter defibrillators. Circulation 1991;84:558-566.
13. Anderson M, Poloniecki J, Stein T, Ward DE, Rowland E, Camm AJ. Ejection fraction alone predicts recurrence of arrhythmias in implantable cardioverter defibrillator patients. Eur Heart J 1993;14(Suppl.):167 (Abstract).
14. Kou WH, Calkins H, Lewis RR, Bolling SF, Kirsch MM, Langberg JJ, de Buitleir M, Sousa J, El-Atassi R, Morady F. Incidence of loss of consciousness during automatic implantable cardioverter-defibrillator shocks. Ann Intern Med 1991; 115:942-945.
15. Keelan ET, Dhala A, Sra J, Axtell K, Maglio C, Jazzayeri MR, Blanck Z, Deshpande S, Biehl M, Akhtar M. Driving safety in patients with implantable cardioverter-defibrillators: A single center experience. J Am Coll Cardiol 1995; 145A (Abstract).
16. Zilo P, Luceri RM, Vardeman LL. Driving after implantation of a cardioverter-defibrillator. PACE Pacing Clin Electrophysiol 1994;17(Part II):781 (Abstract).
17. Jenkins LS, Davis PG, Dunbar SB, Hawthorne MH, Porter L. Driving behavior and device firings reported by patients 1,3 & 6 months post implantation. PACE Pacing Clin Electrophysiol 1995;18 (Part II):945.
18. Finch NJ, Leman RB, Kratz JM, Gillette PC. Driving safety among patients with automatic implantable cardioverter defibrillator. JAMA 1993;270:1587-1588.
19. Larsen GC, Stupey MR, Walance CG, Griffith KK, Cutler JE, Kron J, McAnulty JH. Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia: Implications for driving restrictions. JAMA 1994;271:1335-1339.
20. Tucker KJ, Conti JB, King LC, Reilly RE, Curtis AB. Driving behavior after implantation of cardioverter-defibrillators. PACE Pacing Clin Electrophysiol 1994; 17(Part II): 781 (Abstract).
21. Myerburg RJ, Davis JH. The medical ecology of public safety. I: Sudden death due to coronary heart disease. Am Heart J 1964; 68:586-595.
22. Bowen DA. Deaths of drivers of automobiles due to trauma and ischemic heart disease, a survey and assessment. Forensic Sci 1973; 2:285-290.
23. DiCarlo LA, Winston SA, Honoway S, Reed P. Driving restrictions advised by midwestern cardiologists implanting cardioverter defibrillators: Present practices, criteria utilized, and compatibility with existing state laws. PACE Pacing Clin Electrophysiol 1992;15:1131-1136.
24. Jung W, Anderson M, Camm AJ, Joetdans L, Petch MC, Rosenqvist M, Santini M, Luederitz B, on behalf of the Study Group on "ICD and Driving" of the working groups on cardiac pacing and arrhythmias of the European Society of Cardiology. Eur Heart J 1997;18:1210-1219.
25. Epstein AE, Miles WM, Benditt DG, Camm AJ, Darling EJ, Friedman PL, Garson A Jr, Harvey JC, Kidwell GA, Klein GJ, Levine PA, Marchlinski FE, Prystowsky EN, Wilkoff BL. Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology. Circulation 1996;94:1147-1166.